Pairwise and Bayer Expand CRISPR Leafy Greens Market Through Licensing Agreement

This licensing deal is part of Bayer’s new open innovation approach, launched to leverage opportunities for genome edited fruits and vegetables. The agreement allows Bayer to further develop and commercialize 10 varieties of Pairwise-edited greens, and to develop and breed for new varieties with the technology.